| 1 |
29727629 | Losartan prevents the imbalance between renal dopaminergic and renin angiotensin systems induced by fructose overload. l-Dopa/dopamine index as new potential biomarker of renal dysfunction. | 2018 Aug |
1 |
| 2 |
28577742 | Dual renin-angiotensin system blockade for nephroprotection. | 2017 Apr |
1 |
| 3 |
27548072 | Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial. | 2016 Nov |
1 |
| 4 |
25655494 | Profibrosing effect of angiotensin converting enzyme inhibitors in human lung fibroblasts. | 2015 Apr |
1 |
| 5 |
21326341 | Effect of celecoxib on the antihypertensive effect of losartan in a rat model of renovascular hypertension. | 2011 Feb |
1 |
| 6 |
21331055 | Effect of angiotensin AT1 receptor blockade on sympathetic responses to handgrip in healthy men. | 2011 May |
1 |
| 7 |
18250276 | Letter regarding article by Hood et al, "The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio". | 2008 Feb 5 |
2 |
| 8 |
18475165 | Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study. | 2008 Jun |
1 |
| 9 |
17222813 | Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms. | 2007 Feb |
1 |
| 10 |
17524880 | Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril. | 2007 May |
1 |
| 11 |
17703637 | Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke. | 2007 |
1 |
| 12 |
16685219 | Renin increments the inward calcium current in the failing heart. | 2006 Jun |
3 |
| 13 |
15743363 | A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension. | 2005 Mar |
1 |
| 14 |
16169319 | Effects of eplerenone versus losartan in patients with low-renin hypertension. | 2005 Sep |
1 |
| 15 |
15218473 | Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury. | 2004 Jul |
1 |
| 16 |
12543883 | Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy. | 2003 Feb |
1 |
| 17 |
14638911 | Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. | 2003 Dec |
1 |
| 18 |
11791032 | Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension. | 2002 Jan |
1 |
| 19 |
11971755 | Losartan decreases glomerular filtration rate in isolated perfused porcine slaughterhouse kidneys. | 2002 Mar-Apr |
2 |
| 20 |
12073593 | [Comparative effects of losartan and amlodipine on activities of sympathetic nerve, renin-angiotensin-aldosterone system and brain natriuretic peptide in the elderly hypertensive patients]. | 2002 May |
1 |
| 21 |
12233220 | [Prevention of type II diabetes by inhibiting the renin-angiotensin system]. | 2002 Jul |
1 |
| 22 |
12563562 | Regression of left ventricular hypertrophy: hoping for a longer life. | 2002 Sep |
1 |
| 23 |
11479463 | Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis. | 2001 Aug |
1 |
| 24 |
11509454 | Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter. | 2001 Aug 17 |
2 |
| 25 |
11523316 | Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension. | 2001 Apr |
1 |
| 26 |
10821336 | Fibrinolytic function in diuretic-induced volume depletion. | 2000 Apr |
1 |
| 27 |
10862636 | Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy. | 2000 Jul |
1 |
| 28 |
10885588 | Pharmacokinetics and blood pressure response of losartan in end-stage renal disease. | 2000 Jun |
1 |
| 29 |
11130773 | Effect of losartan on angiotensin II-mediated endothelin and prostanoid excretion in humans. | 2000 Dec |
1 |
| 30 |
28425793 | Is it Possible to Differentiate between Angiotensin II Type 1 (AT1) Receptor Blockers in Normotensive Volunteers? | 2000 |
1 |
| 31 |
10073846 | Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan. | 1999 Feb 15 |
1 |
| 32 |
10404959 | Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan. | 1999 Apr |
3 |
| 33 |
10410812 | [Combined blockade of the renin-angiotensin system]. | 1999 Jun |
1 |
| 34 |
10424062 | [Neurohumoral changes in patients with mild and moderate forms of hypertension under the influence of losartan]. | 1999 Mar |
1 |
| 35 |
10483973 | EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction. | 1999 Sep |
1 |
| 36 |
10576791 | Blood pressure and renin angiotensin system responses to initiation of treatment with captopril or losartan in heart failure. | 1999 Sep |
1 |
| 37 |
10608722 | Effects of losartan on low-density lipoprotein apheresis. | 1999 Nov |
1 |
| 38 |
9604859 | Losartan in Cushing's syndrome. | 1998 Mar |
1 |
| 39 |
9853270 | Regulation of human renin gene promoter activity: a new negative regulatory region determines the responsiveness to TNF alpha. | 1998 Dec |
1 |
| 40 |
9040450 | Additive effects of losartan and enalapril on blood pressure and plasma active renin. | 1997 Feb |
3 |
| 41 |
9247766 | Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects. | 1997 Jul-Aug |
2 |
| 42 |
8549037 | Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men. | 1996 Jan |
1 |
| 43 |
8913546 | Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension. | 1996 |
1 |
| 44 |
7595905 | Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension. | 1995 Apr |
1 |
| 45 |
7596116 | Haemodynamic and renal responses to oral losartan potassium during salt depletion or salt repletion in normal human volunteers. | 1995 Apr |
1 |
| 46 |
7641363 | Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. | 1995 Aug 15 |
2 |
| 47 |
7843751 | Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. | 1995 Jan |
3 |
| 48 |
8554732 | Effect of acute and chronic losartan therapy on active and inactive renin and active renin glycoforms. | 1995 Nov |
15 |
| 49 |
8751032 | Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist. | 1995 |
1 |
| 50 |
8998251 | The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension. | 1995 Dec |
1 |